abstract |
The invention relates to sterile filtered nanoparticulate compositions of beclomethasone and/or budesonide having as a surface stabilizer tyloxapol and, optionally, one or more secondary surface stabilizers adsorbed onto the surfaces thereof. The nanoparticulate compositions have an optimal effective average particle size of less than about 150 nm. |